trimetazidine has been researched along with pyruvic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakovic, D; Bulat, C; Cavar, M; Dujic, Z; Fabijanic, D; Karanovic, N; Kraljevic, J; Lavie, CJ; Ljubkovic, M; Marinovic, J; Wisloff, U | 1 |
1 other study(ies) available for trimetazidine and pyruvic acid
| Article | Year |
|---|---|
Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.
Topics: Aged; Coronary Artery Disease; Female; Humans; Male; Mitochondria, Heart; Oxidation-Reduction; Palmitoylcarnitine; Pyruvic Acid; Trimetazidine | 2016 |